Literature DB >> 23940249

Factors associated with late detection of critical congenital heart disease in newborns.

April L Dawson1, Cynthia H Cassell, Tiffany Riehle-Colarusso, Scott D Grosse, Jean Paul Tanner, Russell S Kirby, Sharon M Watkins, Jane A Correia, Richard S Olney.   

Abstract

OBJECTIVES: Critical congenital heart disease (CCHD) was recently added to the US Recommended Uniform Screening Panel for newborns. This study assessed whether maternal/household and infant characteristics were associated with late CCHD detection.
METHODS: This was a statewide, population-based, retrospective, observational study of infants with CCHD born between 1998 and 2007 identified by using the Florida Birth Defects Registry. We examined 12 CCHD conditions that are primary and secondary targets of newborn CCHD screening using pulse oximetry. We used Poisson regression models to analyze associations between selected characteristics (eg, CCHD type, birth hospital nursery level [highest level available in the hospital]) and late CCHD detection (defined as diagnosis after the birth hospitalization).
RESULTS: Of 3603 infants with CCHD and linked hospitalizations, CCHD was not detected during the birth hospitalization for 22.9% (n = 825) of infants. The likelihood of late detection varied by CCHD condition. Infants born in a birth hospital with a level I nursery only (adjusted prevalence ratio: 1.9 [95% confidence interval: 1.6-2.2]) or level II nursery (adjusted prevalence ratio: 1.5 [95% confidence interval: 1.3-1.7]) were significantly more likely to have late-detected CCHD compared with infants born in a birth hospital with a level III (highest) nursery.
CONCLUSIONS: After controlling for the selected characteristics, hospital nursery level seems to have an independent association with late CCHD detection. Thus, perhaps universal newborn screening for CCHD could be particularly beneficial in level I and II nurseries and may reduce differences in the frequency of late diagnosis between birth hospital facilities.

Entities:  

Keywords:  congenital heart disease; neonatal screening

Mesh:

Year:  2013        PMID: 23940249      PMCID: PMC4617641          DOI: 10.1542/peds.2013-1002

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Levels of neonatal care.

Authors:  Ann R Stark
Journal:  Pediatrics       Date:  2004-11       Impact factor: 7.124

3.  Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: Featuring critical congenital heart defects targeted for pulse oximetry screening.

Authors:  Cara T Mai; Tiffany Riehle-Colarusso; Alissa O'Halloran; Janet D Cragan; Richard S Olney; Angela Lin; Marcia Feldkamp; Lorenzo D Botto; Russel Rickard; Marlene Anderka; Mary Ethen; Carol Stanton; Joan Ehrhardt; Mark Canfield
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-12

4.  Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?

Authors:  Cora Peterson; April Dawson; Scott D Grosse; Tiffany Riehle-Colarusso; Richard S Olney; Jean Paul Tanner; Russell S Kirby; Jane A Correia; Sharon M Watkins; Cynthia H Cassell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-09-02

5.  Validity of hospital discharge data for identifying infants with cardiac defects.

Authors:  Barbara Kathleen Frohnert; Richard Charles Lussky; Maureen Anne Alms; Nancy J Mendelsohn; Daniel Michael Symonik; Myron Clifford Falken
Journal:  J Perinatol       Date:  2005-11       Impact factor: 2.521

6.  Failure to diagnose congenital heart disease in infancy.

Authors:  K S Kuehl; C A Loffredo; C Ferencz
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

7.  Contribution of birth defects to infant mortality in the United States.

Authors:  Joann Petrini; Karla Damus; Rebecca Russell; Karalee Poschman; Michael J Davidoff; Donald Mattison
Journal:  Teratology       Date:  2002

8.  Risk factors for not delivering in a level III unit before 32 weeks of gestation: results from a population-based study in Paris and surrounding districts in 2003.

Authors:  Jennifer Zeitlin; Cletus D Gwanfogbe; Dominique Delmas; Hugo Pilkington; Pierre-Henri Jarreau; Jean-Louis Chabernaud; Gérard Bréart; Emile Papiernik
Journal:  Paediatr Perinat Epidemiol       Date:  2008-03       Impact factor: 3.980

9.  Neonatal screening for critical cardiovascular anomalies using pulse oximetry.

Authors:  Sarah Prudhoe; Majd Abu-Harb; Sam Richmond; Christopher Wren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-01-22       Impact factor: 5.747

10.  Maternal characteristics associated with place of delivery and neonatal mortality rates among very-low-birthweight infants, Georgia.

Authors:  Julia L Samuelson; James W Buehler; Dianne Norris; Ramses Sadek
Journal:  Paediatr Perinat Epidemiol       Date:  2002-10       Impact factor: 3.980

View more
  10 in total

1.  Automated detection of coarctation of aorta in neonates from two-dimensional echocardiograms.

Authors:  Franklin Pereira; Alejandra Bueno; Andrea Rodriguez; Douglas Perrin; Gerald Marx; Michael Cardinale; Ivan Salgo; Pedro Del Nido
Journal:  J Med Imaging (Bellingham)       Date:  2017-01-24

2.  Racial/ethnic differences in survival of United States children with birth defects: a population-based study.

Authors:  Ying Wang; Gang Liu; Mark A Canfield; Cara T Mai; Suzanne M Gilboa; Robert E Meyer; Marlene Anderka; Glenn E Copeland; James E Kucik; Wendy N Nembhard; Russell S Kirby
Journal:  J Pediatr       Date:  2015-01-29       Impact factor: 4.406

Review 3.  Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.

Authors:  Richard S Olney; Elizabeth C Ailes; Marci K Sontag
Journal:  Semin Perinatol       Date:  2015-04       Impact factor: 3.300

4.  Universal state newborn screening programs can reduce health disparities.

Authors:  Jeffrey P Brosco; Scott D Grosse; Lainie Friedman Ross
Journal:  JAMA Pediatr       Date:  2015-01       Impact factor: 16.193

5.  Photoplethysmographic waveform characteristics of newborns with coarctation of the aorta.

Authors:  L Palmeri; G Gradwohl; M Nitzan; E Hoffman; Y Adar; Y Shapir; R Koppel
Journal:  J Perinatol       Date:  2016-09-29       Impact factor: 2.521

6.  Projected growth of the adult congenital heart disease population in the United States to 2050: an integrative systems modeling approach.

Authors:  Catherine P Benziger; Karen Stout; Elisa Zaragoza-Macias; Amelia Bertozzi-Villa; Abraham D Flaxman
Journal:  Popul Health Metr       Date:  2015-10-15

7.  Indigenous Ethnicity and Low Maternal Education Are Associated with Delayed Diagnosis and Mortality in Infants with Congenital Heart Defects in Panama.

Authors:  Franz Castro; Julio Zúñiga; Gladys Higuera; María Carrión Donderis; Beatriz Gómez; Jorge Motta
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

Review 8.  Databases for Congenital Heart Defect Public Health Studies Across the Lifespan.

Authors:  Tiffany J Riehle-Colarusso; Lisa Bergersen; Craig S Broberg; Cynthia H Cassell; Darryl T Gray; Scott D Grosse; Jeffrey P Jacobs; Marshall L Jacobs; Russell S Kirby; Lazaros Kochilas; Asha Krishnaswamy; Arianne Marelli; Sara K Pasquali; Thalia Wood; Matthew E Oster
Journal:  J Am Heart Assoc       Date:  2016-10-26       Impact factor: 5.501

9.  Birth prevalence and late diagnosis of critical congenital heart disease: A population-based study from a middle-income country.

Authors:  Mohd Nizam Mat Bah; Mohd Hanafi Sapian; Emieliyuza Yusnita Alias
Journal:  Ann Pediatr Cardiol       Date:  2020-09-17

10.  Major heart defects: the diagnostic evaluations of first-year-olds.

Authors:  Jan Pavlicek; Eva Klaskova; Sabina Kapralova; Alzbeta Moravova Palatova; Alicja Piegzova; Richard Spacek; Tomas Gruszka
Journal:  BMC Pediatr       Date:  2021-11-30       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.